Patent details

EP2605789 Title: MODIFIED RELAXIN POLYPEPTIDES AND THEIR USES

Basic Information

Publication number:
EP2605789
PCT Application Number:
US2011048157
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP118187582
PCT Publication Number:
WO2012024452
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MODIFIED RELAXIN POLYPEPTIDES AND THEIR USES
French Title of Invention:
POLYPEPTIDES DE RELAXINE MODIFIÉS ET LEURS UTILISATIONS
German Title of Invention:
MODIFIZIERTE RELAXINPOLYPEPTIDE UND IHRE VERWENDUNGEN
SPC Number:

Dates

Filing date:
17/08/2011
Grant date:
05/06/2019
EP Publication Date:
26/06/2013
PCT Publication Date:
23/02/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/06/2019
EP B1 Publication Date:
05/06/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
17/08/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/05/2019
 
 

Name:
Ambrx, Inc.
Address:
10975 North Torrey Pines Road, Suite 100, La Jolla, CA 92037, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
31/07/2019
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
KRAYNOV, Vadim
Address:
United States (US)

2

Name:
SULLIVAN, Lorraine
Address:
United States (US)

3

Name:
PINKSTAFF, Jason
Address:
United States (US)

4

Name:
HEWET, Amha
Address:
United States (US)

5

Name:
KNUDSEN, Nick
Address:
United States (US)

6

Name:
DE DIOS, Kristine
Address:
United States (US)

Priority

Priority Number:
374582 P
Priority Date:
17/08/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/22; A61P 9/00; A61P 9/10; A61P 17/02; A61P 25/28; A61P 31/00; C07H 21/04; C07K 1/04; C07K 14/64; C07K 17/08; C12N 1/19; C12N 1/21; C12P 21/02;

Publication

European Patent Bulletin

Issue number:
201923
Publication date:
05/06/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/09/2025
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
14/08/2024
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
31/07/2019 Power Of Attorney 1
07/08/2019 Outgoing Correspondence 1
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56